Antirheumatic agents.
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000962:Antimalarials / Q000627:therapeutic use; D001241:Aspirin / Q000008:administration & dosage / Q000378:metabolism / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D002738:Chloroquine / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D006046:Gold / Q000627:therapeutic use; D006801:Humans; D006886:Hydroxychloroquine / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007213:Indomethacin / Q000627:therapeutic use; D010396:Penicillamine / Q000627:therapeutic use; D010653:Phenylbutazone / Q000627:therapeutic use; D010666:Phenylpropionates / Q000627:therapeutic use; D012216:Rheumatic Diseases / Q000188:drug therapy* / Q000503:physiopathology; D012459:Salicylates / Q000627:therapeutic use; D013467:Sulindac / Q000627:therapeutic use; D014046:Tolmetin / Q000627:therapeutic use
D000305:Adrenal Cortex Hormones; D000962:Antimalarials; D007166:Immunosuppressive Agents; D010666:Phenylpropionates; D012459:Salicylates; D013467:Sulindac; D006886:Hydroxychloroquine; D006046:Gold; D002738:Chloroquine; D003520:Cyclophosphamide; D014046:Tolmetin; D010653:Phenylbutazone; D010396:Penicillamine; D001379:Azathioprine; D001241:Aspirin; D007213:Indomethacin